|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics. CA Cancer J Clin. 59:225–249. 2009.
|
|
2
|
Lau M, Le A and El-Serag HB: Non-cardia
gastric adenocarcinoma remains an important and deadly cancer in
the United States: secular trends in incidence and survival. Am J
Gastroenterol. 101:2485–2492. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cervantes A, Roselló S, Roda D and
Rodríguez-Braun E: The treatment of advanced gastric cancer:
current strategies and future perspectives. Ann Oncol. 19:103–107.
2008. View Article : Google Scholar
|
|
4
|
Tham CK, Choo SP, Poon DYH, et al:
Capecitabine with radiation is an effective adjuvant therapy in
gastric cancers. World J Gastroenterol. 16:3709–3715. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Watanabe T, Kume K, Taip M, et al: Gastric
mucosal cancer smaller than 7 mm can be treated with conventional
endoscopic mucosal resection as effectively as with endoscopic
submucosal dissection. Hepatogastroenterology. 57:668–673.
2010.
|
|
6
|
Kang HC, Kim IJ, Park HW, et al:
Regulation of MDK expression in human cancer cells modulates
sensitivities to various anticancer drugs: MDK overexpression
confers to a multi-drug resistance. Cancer Lett. 247:40–47. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yin F, Shi YQ, Zhao WP, Xiao B, Miao JY
and Fan DM: Suppression of P-gp induced multiple drug resistance in
a drug resistant gastric cancer cell line by over-expression of
Fas. World J Gastroenterol. 6:664–670. 2000.PubMed/NCBI
|
|
8
|
Sherr CJ: Cancer cell cycles. Science.
274:1672–1677. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jacks T and Weinberg RA: Cell-cycle
control and its watchman. Nature. 381:643–644. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Collins K, Jacks T and Pavletich NP: The
cell cycle and cancer. Proc Natl Acad Sci USA. 94:2776–2778. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Peter M and Herskowitz I: Joining the
complex: cyclin-dependent kinase inhibitory proteins and the cell
cycle. Cell. 79:181–184. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xia Z, Dickens M, Raingeaud J, Davis RJ
and Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases
on apoptosis. Science. 270:1326–1331. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thornton TM and Rincon M: Non-classical
p38 map kinase functions: cell cycle checkpoints and survival. Int
J Biol Sci. 5:44–51. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Han J and Sun P: The pathways to tumor
suppression via route p38. Trends Biochem Sci. 32:364–371. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liotta LA: Tumor invasion and
metastasis-role of extracellular matrix: Rhoads Memorial Award
Lecture. Cancer Res. 46:1–7. 1986.PubMed/NCBI
|
|
16
|
Matrisian LM: Metalloproteinases and their
inhibitors in matrix remodeling. Trends Genet. 6:121–125. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sampieri CL, de la Peña S, Ochoa-Lara M,
Zenteno-Cuevas R and León-Córdoba K: Expression of matrix
metalloproteinases 2 and 9 in human gastric cancer and superficial
gastritis. World J Gastroenterol. 16:1500–1505. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zheng H, Takahashi H, Murai Y, et al:
Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth,
invasion, metastasis and angiogenesis of gastric carcinoma.
Anticancer Res. 26:3579–3583. 2006.PubMed/NCBI
|
|
19
|
Yamanaka N, Morisaki T, Nakashima H, et
al: Interleukin 1beta enhances invasive ability of gastric
carcinoma through nuclear factor-kappaB activation. Clin Cancer
Res. 10:1853–1859. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bond M, Rosalind P, Fabunmi P, Baker AH
and Newby AC: Synergistic upregulation of metalloproteinase-9 by
growth factors and inflammatory cytokines: an absolute requirement
for transcription factor NF-kappa B. FEBS Lett. 435:29–34. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sato H, Kita M and Seiki M: v-Src
activates the expression of 92-kDa type IV collagenase gene through
the AP-1 site and the GT box homologous to retinoblastoma control
elements. A mechanism regulating gene expression independent of
that by inflammatory cytokines. J Biol Chem. 268:23460–23468.
1993.PubMed/NCBI
|
|
22
|
Sato H and Seiki M: Regulatory mechanism
of 92 kDa type IV collagenase gene expression which is associated
with invasiveness of tumor cells. Oncogene. 8:395–405.
1993.PubMed/NCBI
|
|
23
|
Farina AR, Tacconelli A, Vacca A, Maroder
M, Gulino A and Mackay AR: Transcriptional up-regulation of matrix
metalloproteinase-9 expression during spontaneous epithelial to
neuroblast phenotype conversion by SK-N-SH neuroblastoma cells,
involved in enhanced invasivity, depends upon GT-box and nuclear
factor kappaB elements. Cell Growth Differ. 10:353–367. 1999.
|
|
24
|
Ahn DK: Illustrated Book of Korean
Medicinal Herbs. Kyohak Publishing Co; Seoul: pp. 6282003
|
|
25
|
Lim JC, Park JH, Budesinsky M, et al:
Antimutagenic constituents from the thorns of Gleditsia
sinensis. Chem Pharm Bull. 53:561–564. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou L, Li D, Wang J, Liu Y and Wu J:
Antibacterial phenolic compounds from the spines of Gleditsia
sinensis Lam. Nat Prod Res. 21:283–291. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li WH, Zhang XM, Tian RR, Zheng YT, Zhao
WM and Qiu MH: A new anti-HIV lupane acid from Gleditsia
sinensis Lam. J Asian Nat Prod Res. 9:551–555. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shin TY and Kim DK: Inhibitory effect of
mast cell-dependent anaphylaxis by Gleditsia sinensis. Arch
Pharm Res. 23:401–406. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Park E and Shin MJ: Anti-inflammatory
activity of aqueous extract from Gleditsiae Spina. Arch
Pharm Res. 37:124–128. 1993.
|
|
30
|
Panchal RG: Novel therapeutic strategies
to selectively kill cancer cells. Biochem Pharmacol. 55:247–252.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee SJ, Cho YH, Kim H, et al: Inhibitory
effects of the ethanol extract of Gleditsia sinensis thorns
on human colon cancer HCT116 cells in vitro and in
vivo. Oncol Rep. 22:1505–1512. 2009.PubMed/NCBI
|
|
32
|
Macleod KF, Sherry N, Hannon G, et al:
p53-dependent and independent expression of p21 during cell growth,
differentiation, and DNA damage. Genes Dev. 9:935–944. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chambard JC, Lefloch R, Pouyssegur J and
Lenormand P: ERK implication in cell cycle regulation. Biochim
Biophys Acta. 1773:1299–1310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Malumbres M, Pérez De Castro I, Hernández
MI, Jiménez M, Corral T and Pellicer A: Cellular response to
oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor
p15(INK4b). Mol Cell Biol. 20:2915–2925. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim S, Choi MG, Lee HS, et al: Silibinin
suppresses TNF-alpha-induced MMP-9 expression in gastric cancer
cells through inhibition of the MAPK pathway. Molecules.
14:4300–4311. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Moon SK, Cha BY and Kim CH: ERK1/2
mediates TNF-alpha-induced matrix metalloproteinase-9 expression in
human vascular smooth muscle cells via the regulation of NF-kappaB
and AP-1: involvement of the ras dependent pathway. J Cell Physiol.
198:417–427. 2004. View Article : Google Scholar
|
